About Cocrystal Pharma, Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
19805 N. Creek Parkway, Bothell, Washington 98011, US
Description
Information
Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.

Cocrystal Pharma, Inc. Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Cocrystal Pharma, Inc.

What is Cocrystal Pharma, Inc. email format?

The widely used Cocrystal Pharma, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Cocrystal Pharma, Inc. customer service number?

To contact Cocrystal Pharma, Inc. customer service number in your country click here to find.


Who is the CEO of Cocrystal Pharma, Inc.?

James J Martin is the CEO of Cocrystal Pharma, Inc.. Or you may call +1.3058610075


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more